Hercules Capital Inc (N:HTGC)
Business Focus: Venture Capital
Apr 24, 2024 06:00 am ET
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), is celebrating its 20th year of originations activity by reaching the $20.0 billion milestone in total debt commitments.
Apr 18, 2024 06:00 am ET
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2024 financial res
Mar 27, 2024 06:00 am ET
Hercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Fitch Ratings, Inc. (“Fitch”) has affirmed Hercules’
Mar 21, 2024 06:00 am ET
Hercules Capital Receives Confirmed BBB Investment Grade Rating with Revised Outlook to Positive from Morningstar DBRS
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Morningstar DBRS (“DBRS”) has confirmed Hercules’ inv
Feb 20, 2024 06:00 am ET
Hercules Capital Announces Upcoming Event for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be part
Feb 15, 2024 04:07 pm ET
Hercules Capital Reports Fourth Quarter and Full-Year 2023 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the fourth quarter and full-year
Feb 13, 2024 06:02 am ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Fourth Quarter 2023
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a fourth qu
Feb 13, 2024 06:00 am ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 per Share
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a new supp
Jan 25, 2024 06:00 am ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2023 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 202
Jan 23, 2024 04:05 pm ET
Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital
Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, today announced the closing of an up to...
Jan 02, 2024 02:00 am ET
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), announces it and its wholly-owned subsidiary, Verona Pharma, Inc. (the “Company”), have entered into a debt financing facility (“debt facility”) providing the Company with access to up to $400...
Dec 22, 2023 04:00 pm ET
enGene Announces Expanded $50 Million Debt Facility with Hercules Capital
BOSTON and MONTREAL, Dec. 22, 2023 /CNW/ - enGene Holdings Inc. ("enGene," Nasdaq: ENGN), a clinical-stage genetic medicines company whose lead EG-70 program is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), announced today that it has entered into an amended USD $50 million loan agreement (the "Loan Agreement") with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). Under the Loan Agreement, which has a term of four years, $22.5 million has been advanced to enGene under a non-revolving term loan and, subject to certain clinical and financial milestones, u
Dec 22, 2023 04:00 pm ET
enGene Announces Expanded $50 Million Debt Facility with Hercules Capital
BOSTON and MONTREAL, Dec. 22, 2023 /PRNewswire/ - enGene Holdings Inc. ("enGene," Nasdaq: ENGN), a clinical-stage genetic medicines company whose lead EG-70 program is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), announced today that it has entered into an amended USD $50 million loan agreement (the "Loan Agreement") with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). Under the Loan Agreement, which has a term of four years, $22.5 million has been advanced to enGene under a non-revolving term loan and, subject to certain clinical and financial milest
Dec 14, 2023 08:00 am ET
Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today announced an amendment to its term loan facility from Hercules Capital, Inc....
Nov 09, 2023 04:10 pm ET
Hercules Capital Receives SBA “Green Light” Letter to Submit Its Fourth SBIC License Application
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that the U.S. Small Business Administration (“SBA”) has is
Nov 08, 2023 06:00 am ET
Hercules Capital Announces Upcoming Events for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be part
Nov 02, 2023 04:10 pm ET
Hercules Capital Reports Third Quarter 2023 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended Septembe
Oct 31, 2023 06:00 am ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Third Quarter 2023
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a third qua
Oct 12, 2023 06:00 am ET
Hercules Capital Announces Date for Release of Third Quarter 2023 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2023 financial res
Oct 04, 2023 06:00 am ET
Hercules Capital Receives Reaffirmed Baa3 Investment Grade Credit and Corporate Rating from Moody’s Investors Service
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Moody’s Investors Service, Inc. (“Moody’s”) has reaff
Sep 25, 2023 06:00 am ET
Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Nikos Theodosopoulos was appointed to serve as an ind
Aug 31, 2023 06:00 am ET
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. (“KBRA”) has reaffirme
Aug 07, 2023 08:42 pm ET
Hercules Capital, Inc. Prices Upsized Public Offering of Common Stock
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) today announced that it has priced its upsized public offering of 6,500,000 shares of its common stock. Hercules has also granted the underwriters an option to purchase up to an additional 975,000 shares of its common stock. The offering is subject to customary closing conditions and is expected to close on August 10, 2023.
Aug 07, 2023 04:17 pm ET
Hercules Capital, Inc. Announces Public Offering of Common Stock
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) today announced that it plans to make a public offering of 6,000,000 shares of its common stock. Hercules also expects to grant the underwriters for the offering an option to purchase up to an additional 900,000 shares of its common stock.
Aug 03, 2023 04:10 pm ET
Hercules Capital Reports Second Quarter 2023 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the second quarter
Aug 03, 2023 08:00 am ET
X4 Pharmaceuticals Closes $115 Million Loan Facility with Hercules Capital
X4 Pharmaceuticals (Nasdaq: XFOR), a leader in the discovery and development of novel small-molecule therapeutics to benefit people with rare diseases of the immune system, today announced the closing of a $115 million loan facility with Hercules...
Aug 01, 2023 06:00 am ET
Hercules Capital Increases Its Total Cash Distribution to $0.48 per Share for the Second Quarter 2023
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has increased and declar
Jul 24, 2023 09:00 am ET
Heron Therapeutics Announces $30 Million Private Placement Financing
SAN DIEGO, July 24, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, announced today that it has entered into a securities purchase agreement to sell in a private placement to institutional investors, led by existing investor Rubric Capital Management LP and including existing and new investors, including Velan Capital, Clearline Capital and Hercules Capital, Inc. (NYSE: HTGC), 20,734,917 shares of its common sto
Jul 10, 2023 06:00 am ET
Hercules Capital Announces Date for Release of Second Quarter 2023 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2023 financial re
May 15, 2023 11:00 am ET
Tipalti Secures $150 Million in Growth Financing from JPMorgan Chase Bank and Hercules Capital
Funding Will Fuel Continued Growth and Product Innovation for FinTech Leader; Company Also Announces Three New Additions to Executive Team
May 11, 2023 06:00 am ET
Hercules Capital Announces Date of 2023 Annual Meeting of Stockholders
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), will conduct its 2023 Annual Meeting of Stockholders by virtual meeting on Thursday, June 22, 2023 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was mailed separately on or about May 10, 2023 to shareholders of record as of April 21, 2023.
May 04, 2023 04:10 pm ET
Hercules Capital Reports First Quarter 2023 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the first quarter ended March 31
May 02, 2023 06:00 am ET
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2023
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a first qua
Apr 20, 2023 06:00 am ET
Hercules Capital Announces Date for Release of First Quarter 2023 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2023 financial res
Apr 04, 2023 06:00 am ET
Hercules Capital Receives BBB- Reaffirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Fitch Ratings, Inc. (“Fitch”) has reaffirmed Hercules
Mar 27, 2023 06:00 am ET
Hercules Adviser LLC Establishes A New Institutional Private Credit Lending Program
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules Capital” or the “Company”) today announced that Hercules Adviser LLC (“Hercules Adviser”), a wholly-owned subsidiary of Hercules Capital, announced it has established a new institutional private credit lending program. The new private credit lending program was established to support the venture and growth stage companies that are being impacted by the recent market events across the venture and growth stage lending ecosystem.
Mar 22, 2023 06:00 am ET
Hercules Capital Increases Its Committed Letter of Credit Facility with SMBC
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced it has increased its committed letter of credit facility with Sumitomo Mitsui Banking Corporation (“SMBC”) by $75.0 million for a total of $175.0 million in credit capacity subject to borrowing base, leverage and other restrictions. The increased credit facility also includes an uncommitted accordion feature o
Mar 14, 2023 10:02 am ET
EPAM Welcomes DeAnne Aguirre to its Board of Directors
Bringing extensive consulting expertise and a diverse background working with large and complex domestic and international business units
Mar 14, 2023 08:05 am ET
Gibraltar Business Capital Launches Gibraltar Equipment Finance
CHICAGO, March 14, 2023 /PRNewswire/ -- Gibraltar Business Capital (GBC) is pleased to announce the launch of its new equipment financing business, Gibraltar Equipment Finance (GEF). GEF provides term financing solutions complementing GBC's asset based lending products and furthers GBC's strong track record of business lending innovation.
Mar 13, 2023 06:00 am ET
Hercules Capital Business Update and Response to the Closure of Silicon Valley Bank
The team at Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) is working collectively with our employees, stockholders, stakeholders, bondholders, rating agencies, portfolio companies, and our portfolio companies’ venture capital and private equity sponsors to navigate the challenges created by the FDIC’s decision to place Silicon
Feb 24, 2023 06:00 am ET
Hercules Capital Announces Upcoming Event for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be part
Feb 16, 2023 04:10 pm ET
Hercules Capital Reports Fourth Quarter and Full-Year 2022 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the fourth quarter
Feb 14, 2023 06:03 am ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 per Share
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a new supp
Feb 14, 2023 06:00 am ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.39 per Share for the Fourth Quarter of 2022
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has increas
Feb 02, 2023 03:01 pm ET
Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD®
RED BANK, N.J., Feb. 2, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the close of the $40 million second tranche under the previously announced term loan facility of up to $125 million with Hercules Capital, Inc. (NYSE: HTGC), a leader in customized financing for companies in life sciences.
Feb 02, 2023 06:00 am ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2022 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and
Dec 21, 2022 04:15 pm ET
Madrigal Pharmaceuticals Announces $300+ Million in Financing Events to Advance Resmetirom Program
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that it has raised $259 million in gross equity (or $255 million in net proceeds) from equity securities issuances and an additional $50 million in liquidity commitments following the...
Dec 07, 2022 06:00 am ET
Hercules Capital Announces Upcoming Event for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be part
Nov 16, 2022 07:00 am ET
Oak Street Health Secures $300 Million in Financing from Hercules Capital and Silicon Valley Bank
SANTA CLARA, Calif., Nov. 16, 2022 /PRNewswire/ -- Silicon Valley Bank, the bank of the world's most innovative companies and investors, and Hercules Capital, Inc. (NYSE: HTGC), today announced that they provided a $300 million credit facility to Oak Street Health (NYSE: OSH), a network of value-based primary care centers for adults on Medicare. The financing is intended to provide Oak Street Health with operational and strategic capital for the next several years.
Nov 16, 2022 06:00 am ET
Hercules Capital Announces Upcoming Events for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team
Nov 03, 2022 07:00 am ET
Kura Oncology Announces Financing Transactions with Bristol Myers Squibb and Hercules Capital, Providing Access to up to $150 Million
Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced a $25 million equity investment from Bristol Myers Squibb (NYSE:...
Nov 02, 2022 04:05 pm ET
Hercules Capital Reports Third Quarter 2022 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended Septembe
Nov 01, 2022 08:00 am ET
Phathom Pharmaceuticals Announces Placement of the Remaining $40 Million in Non-Dilutive Capital under its up to $300 Million Revenue Interest Financing Agreement
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases and disorders, today announced that up to an additional $40 million in non-dilutive...
Oct 25, 2022 07:01 am ET
Gritstone bio Announces Private Placement of $45.0 Million
Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that it has executed a securities purchase agreement to sell, through a private investment in public...
Oct 19, 2022 06:00 am ET
Hercules Capital Announces Date for Release of Third Quarter 2022 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2022
Oct 18, 2022 06:03 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Third Quarter of 2022
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Oct 18, 2022 06:00 am ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.36 per Share for the Third Quarter of 2022
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has increas
Oct 07, 2022 08:00 am ET
Replimune Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel class of tumor-directed oncolytic immunotherapies, today announced that it has obtained a $200 million non-dilutive term loan...
Sep 13, 2022 06:00 am ET
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. (“KBRA”)
Aug 31, 2022 06:12 pm ET
Provention Bio Announces $125 Million Term Loan Facility with Hercules Capital
RED BANK, N.J., Aug. 31, 2022 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the Company has secured a term loan facility of up to $125 million with Hercules Capital, Inc. (NYSE: HTGC), a leader in customized financing for companies in life sciences.
Aug 30, 2022 07:00 am ET
Alladapt Announces Loan Agreement with Hercules Capital
Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, today announced that it has entered into a term loan agreement for up to $50 million...
Aug 15, 2022 07:35 am ET
atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update
atai Life Sciences N.V. (Nasdaq:ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today reported financial results for the quarter ended June 30, 2022, and...
Aug 15, 2022 06:55 am ET
atai Life Sciences Secures Term Loan Facility for up to $175 Million from Hercules Capital
atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the company has entered into a term loan facility for up to $175 million...
Aug 04, 2022 04:05 pm ET
Gritstone Reports Second Quarter 2022 Financial Results and Provides Business Update
-- New credit facility provides financial flexibility entering period of multiple potential milestones -- -- Cash, cash equivalents, marketable securities and restricted cash of $159.2 million as of June 30, 2022 -- -- Gritstone will host a...
Jul 28, 2022 04:10 pm ET
Hercules Capital Reports Second Quarter 2022 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the second quarter ended June 30
Jul 26, 2022 06:03 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Second Quarter of 2022
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Jul 26, 2022 06:00 am ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.35 per Share for the Second Quarter of 2022
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has increased and declar
Jul 21, 2022 04:05 pm ET
Gritstone Establishes Credit Facility for Up to $80 Million with Hercules Capital and Silicon Valley Bank
Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced it has entered into an $80 million credit facility with Hercules Capital, Inc. (NYSE: HTGC) and...
Jul 14, 2022 06:00 am ET
Hercules Capital Announces Date for Release of Second Quarter 2022 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2022
Jun 24, 2022 06:00 am ET
Hercules Capital Announces the Appointment of Ms. DeAnne Aguirre to Its Board of Directors
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that DeAnne Aguirre was appointed to serve as
Jun 23, 2022 04:10 pm ET
Hercules Capital Completes Two Institutional Debt Financings, Raising a Total of $200.0 Million to Support Continued Growth
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced that it has closed two new debt financings raising a total of $200.0 million. Hercules Capital Funding Trust 2022-1, a newly formed wholly owned, indirect subsidiary of Hercules, has issued $150.0 million of class A notes (the “Class A Notes”) and Hercules has closed a private institutional offering in aggregate principal amount of $50.0 million notes due June 2025 (the “June Notes”).
Jun 16, 2022 07:00 am ET
Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million
Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced two financing transactions. The first is a $25...
Jun 15, 2022 06:00 am ET
Hercules Capital Expands Its Credit Facilities to $720 Million to Support Strong Investment Portfolio Growth
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has increased its existing credit facilities with M
May 10, 2022 06:00 am ET
Hercules Capital Receives BBB- Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Fitch Ratings, Inc. (“Fitch”) has assigned Hercules a
May 09, 2022 06:00 am ET
Hercules Capital Announces Date of 2022 Annual Meeting of Stockholders
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), will conduct its 2022 Annual Meeting of Stockholders by virtual meeting on Thursday, June 23, 2022 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was mailed separately on or about May 4, 2022 to shareholders of record as of April 25, 2022.
May 05, 2022 04:10 pm ET
Hercules Capital Reports First Quarter 2022 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the first quarter ended March 31
May 03, 2022 06:03 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the First Quarter of 2022
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
May 03, 2022 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.33 per Share for the First Quarter of 2022
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a first qua
Apr 18, 2022 06:00 am ET
Hercules Receives a BBB Reaffirmed Investment Grade Corporate Rating From DBRS, Inc.
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that DBRS, Inc. (“DBRS Morningstar”) has reaffirmed Hercul
Apr 14, 2022 06:00 am ET
Hercules Capital Announces Date for Release of First Quarter 2022 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2022 financial res
Apr 04, 2022 04:05 pm ET
Viridian Therapeutics Secures Flexible Credit Facility for Up to $75 Million From Hercules Capital
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies, today announced that the Company has entered into a debt financing agreement...
Mar 01, 2022 06:00 am ET
Hercules Capital Announces Upcoming Event for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be part
Feb 22, 2022 04:10 pm ET
Hercules Capital Reports Fourth Quarter and Full-Year 2021 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the fourth quarter and full-year
Feb 22, 2022 06:02 am ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.60 per Share
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a new supp
Feb 22, 2022 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.33 per Share for the Fourth Quarter of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a fourth qu
Feb 08, 2022 07:00 am ET
Lucira Health Secures Debt Facility of Up to $80 Million from Hercules Capital and Silicon Valley Bank
Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that on February 4, 2022,...
Feb 08, 2022 06:00 am ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2021 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 202
Feb 02, 2022 07:00 am ET
Tarsus Completes Enrollment for the Pivotal Phase 3 Saturn-2 Trial of TP-03 to Treat Demodex Blepharitis and Secures $175 Million Credit Facility
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced it has completed enrollment of...
Feb 01, 2022 06:00 am ET
Hercules Capital Enhances C-Suite for Future Growth
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced two internal promotions and one new addition to the execut
Jan 20, 2022 10:35 am ET
Hercules Capital Closes Upsized Public Offering of $350.0 Million 3.375% Notes Due 2027
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has closed an underwritten public offering of $350.0 million in aggregate principal amount of 3.375% notes due January 2027 (the “Notes”).
Jan 14, 2022 05:33 pm ET
Hercules Capital Prices Upsized Public Offering of $350.0 Million 3.375% Notes due 2027
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has priced an underwritten public offering of $350.0 million in aggregate principal amount of 3.375% notes due January 2027 (the “Notes”). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered a
Jan 04, 2022 07:30 am ET
TG Therapeutics Expands Term Loan Facility With Hercules Capital to $200 Million
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that its existing term loan facility agreement with Hercules Capital, Inc. (NYSE: HTGC), has been amended to increase the size of the facility to $200 million, with $70 million funded at...
Nov 29, 2021 06:00 am ET
Hercules Capital Surpasses $2.0 Billion in Annual Gross Debt and Equity Commitments for First Time in History
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it, together with external funds managed by its advis
Nov 10, 2021 06:00 am ET
Hercules Capital Further Strengthens Its Capital Resources With New $100.0 Million Multi-Currency Credit Facility
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that effective November 9, 2021, it has entered into a new
Nov 09, 2021 04:10 pm ET
Hercules Capital Announces Upcoming Events for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be part
Oct 28, 2021 04:10 pm ET
Hercules Capital Reports Third Quarter 2021 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended Septembe
Oct 26, 2021 06:03 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.07 per Share for the Third Quarter of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Oct 26, 2021 06:00 am ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.33 per Share for the Third Quarter of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has increased and declar
Oct 20, 2021 06:00 am ET
Hercules Capital Announces the Appointment of Ms. Pam Randhawa to Its Board of Directors
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Pam Randhawa was appointed to serve as a member of it
Oct 19, 2021 07:30 am ET
Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital
Locus Biosciences, Inc. (“Locus”), a clinical-stage biotechnology company developing a new class of precision engineered bacteriophage treatments for a diverse set of bacterial and inflammatory diseases, today announced that the company has entered...
Oct 14, 2021 06:00 am ET
Hercules Capital Announces Date for Release of Third Quarter 2021 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2021 financial res
Oct 05, 2021 08:00 am ET
Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from Hercules Capital
Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), today announced that the company has entered into a debt facility of up to $30.0 million with Hercules Capital, Inc. (NYSE: HTGC), a specialty financing lender for life science and technology companies....
Sep 27, 2021 08:00 am ET
Corium Secures $235 Million in Debt Financing
BOSTON, Sept. 27, 2021 /PRNewswire/ -- Corium, Inc. (Corium), a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, today announces that it has closed on a $235 million term loan agreement with Hercules Capital, Inc. (NYSE: HTGC), a leader in specialty financing for life science and technology companies. Corium will receive an initial tranche of $100 million, and the remaining funds will be available in three additional tranches upon the achievement of certain pre-defined milestones.
Sep 27, 2021 06:00 am ET
Hercules Capital Delivers a New Record by Surpassing $1.5 Billion of Annual Gross Debt and Equity Commitments
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it, together with external funds managed by its advis
Sep 20, 2021 08:00 am ET
Phathom Pharmaceuticals Secures $200 Million Term Loan Facility from Hercules Capital
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today reported it has obtained a $200 million term loan facility...
Sep 16, 2021 04:10 pm ET
Hercules Capital Closes Public Offering of $325.0 Million 2.625% Notes due 2026
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has closed an underwritten public offering of $325.0 million in aggregate principal amount of 2.625% notes due 2026 (the “Notes”).
Sep 13, 2021 04:41 pm ET
Hercules Capital Prices Public Offering of $325.0 Million 2.625% Notes Due 2026
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has priced an underwritten public offering of $325.0 million in aggregate principal amount of 2.625% notes due September 2026 (the “Notes”). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered
Aug 25, 2021 08:00 am ET
Better Therapeutics Secures $50 Million Debt Facility From Hercules Capital
Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it has secured a loan facility for up to $50 million from Hercules Capital, Inc. (NYSE: HTGC).
Aug 16, 2021 06:30 am ET
BiomX Reports Second Quarter 2021 Financial Results and Provides Business Update
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage cocktails that target specific pathogenic bacteria, today reported financial results and provided a...
Aug 02, 2021 06:00 am ET
Hercules Capital Reaches $1.0 Billion Milestone in Annual Debt and Equity Commitments for the Fourth Consecutive Year
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has originated more than $1.0 billion year-to-date
Jul 29, 2021 04:10 pm ET
Hercules Capital Reports Second Quarter 2021 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the second quarter ended June 30
Jul 27, 2021 06:01 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.07 Per Share for the Second Quarter Of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Jul 27, 2021 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Second Quarter of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a second qu
Jul 15, 2021 06:00 am ET
Hercules Capital Announces Date for Release of Second Quarter 2021 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2021 financial re
Jun 25, 2021 01:23 pm ET
Hercules Capital Announces the Appointment of Wade Loo to Its Board of Directors
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that effective July 1, 2021, Wade Loo was appointed to the
Jun 08, 2021 06:00 am ET
Hercules Capital Announces Date of 2021 Annual Meeting of Stockholders
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), will conduct its 2021 Annual Meeting of Stockholders by virtual meeting on Thursday, June 24, 2021 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was mailed separately on or about April 30, 2021 to shareholders of record as of April 23, 2021.
Jun 03, 2021 07:01 am ET
Nabriva Agrees to Extension of Principal Debt Repayments Under Existing Loan Agreement with Hercules Capital
Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it has reached an agreement with Hercules...
May 28, 2021 01:05 pm ET
Hercules Capital Announces Its Intention to Fully Redeem its 5.25% Notes due 2025
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its intent to fully redeem approximately $75.0 million (face v
May 19, 2021 08:00 am ET
HiberCell Closes $67.4 Million Series B Financing and Secures $30 Million Debt Facility from Hercules Capital
HiberCell, a biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis, today announced that it has completed a Series B financing round for gross proceeds of $67.4 million. Concurrent to this financing,...
May 14, 2021 08:30 am ET
SCYNEXIS Secures Term Loan Facility for up to $60 Million with Hercules Capital and Silicon Valley Bank
SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported that it has secured a $60 million term loan facility with Hercules...
May 13, 2021 04:03 pm ET
AGTC Announces Expansion of Manufacturing and Analytics Capabilities to Advance Commercialization of Gene Therapy Product Candidates
Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that it has initiated plans...
Apr 29, 2021 04:10 pm ET
Hercules Capital Reports First Quarter 2021 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the first quarter ended March 31
Apr 27, 2021 06:03 am ET
Hercules Capital Announces Fiscal 2021 Supplemental Cash Distribution of $0.28 Per Share
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Apr 27, 2021 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the First Quarter of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a first qua
Apr 15, 2021 06:00 am ET
Hercules Capital Announces Date for Release of First Quarter 2021 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2021 financial res
Mar 25, 2021 06:00 am ET
Hercules Adviser LLC Announces the Closing of Its Inaugural Institutional Private Credit Fund
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced that Hercules Adviser LLC (“Hercules Adviser”), a wholly-owned subsidiary of Hercules Capital, has successfully closed its inaugural institutional private credit fund.
Mar 08, 2021 06:00 am ET
Hercules Capital Receives Baa3 Investment Grade Credit and Corporate Rating from Moody’s Investors Service
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Moody’s Investors Service, Inc. (“Moody’s”) has assig
Mar 04, 2021 04:21 pm ET
Hercules Capital Completes Investment Grade Bond Offering of $50.0 Million of 4.55% Notes due March 2026
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced the completed issuance of a private offering in aggregate principal amount of $50.0 million 4.55% Notes due March 2026 (the “March B Notes”). On November 4, 2020, the Company completed the initial issuance of $50.0 million 4.50% Notes due March 4, 2026, which were initially assigned a BBB+ rating by Kroll Bond Rating Agency.
Mar 02, 2021 06:00 am ET
Hercules Capital Announces Upcoming Event for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be virt
Feb 23, 2021 04:10 pm ET
Hercules Capital Reports Fourth Quarter and Full-Year 2020 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the fourth quarter and full-year
Feb 22, 2021 06:02 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.05 per Share for the Fourth Quarter of 2020
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Feb 22, 2021 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Fourth Quarter of 2020
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a fourth qu
Feb 09, 2021 06:00 am ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2020 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 202
Jan 19, 2021 10:00 am ET
Rapid Growth and Trailblazing Tech in 2020 Positions CloudBolt Software to Redefine Cloud Management in 2021
CloudBolt Software, the enterprise cloud management leader, solidified its position as the intelligent choice for cloud management in 2020. With significant growth and global expansion, two acquisitions, and game-changing innovation, CloudBolt’s...
Nov 18, 2020 10:00 am ET
CloudBolt Announces $35 Million in Series B Funding Led by Insight Partners
CloudBolt Software, the enterprise leader in cloud management and integration solutions, today announced $35M in series B funding, consisting of both equity and venture debt. The equity was led by Insight Partners, a global venture capital and...
Nov 04, 2020 05:03 pm ET
Hercules Capital Announces an Investment Grade Bond Offering Totaling $100.0 Million Due 2026
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced a private offering totaling $100.0 million in aggregate principal amount of $50.0 million 4.50% Notes due March 2026 (the “November Notes”) and $50.0 million 4.55% Notes due March 2026 (the “March Notes”).
Nov 03, 2020 10:57 am ET
Udacity Drives 120% Enterprise and Government Growth in Q3, Secures $75 Million to Continue Momentum
MOUNTAIN VIEW, Calif., Nov. 3, 2020 /PRNewswire/ -- Udacity, which prepares employees and students for careers of the future, today announced its Q3 enterprise and government bookings rose by 120% year-over-year, total bookings increased 80% year-over-year, and ARR increased 260% in H1 2020. In addition, the company has reached profitability and, to continue building on this growth, Udacity has signed a $75 million debt facility, with Hercules Capital (NYSE: HTGC) serving as the underwriter.
Oct 29, 2020 04:10 pm ET
Hercules Capital Reports Third Quarter 2020 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended Septembe
Oct 28, 2020 04:10 pm ET
Hercules Capital Gains Additional Liquidity for New Investments with Approval of Third SBA License
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced it received agency committee approval by the U.S. Small Bu
Oct 27, 2020 06:02 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.02 per Share for the Third Quarter of 2020
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Oct 27, 2020 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Third Quarter of 2020
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a third qua
Oct 22, 2020 06:00 am ET
Hercules Capital Announces Date for Release of Third Quarter 2020 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2020 financial res
Oct 01, 2020 04:30 pm ET
Geron Secures Loan Facility for Up to $75 Million
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it has entered into a loan facility for up to $75 million with Hercules Capital, Inc. (NYSE: HTGC) and Silicon Valley Bank (SVB). The loan facility provides the Company with access to non-dilutive financial resources to support the imetelstat development program, as well as working capital and general corporate purposes.
Sep 29, 2020 07:00 am ET
Axsome Therapeutics Announces $225 Million Term Loan Facility with Hercules Capital
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, has secured a $225 million term loan facility with Hercules Capital, Inc. (NYSE: HTGC)....
Aug 04, 2020 04:05 pm ET
UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital
UNITY Biotechnology (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that it has entered into a $80 million debt facility with Hercules...
Jul 30, 2020 04:10 pm ET
Hercules Capital Reports Second Quarter 2020 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the second quarter ended June 30
Jul 29, 2020 06:00 am ET
Hercules Capital Surpasses $1.0 Billion in Cumulative Distributions to Shareholders since IPO
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that its Board of Directors has declared a second quarter 2
Jul 22, 2020 04:10 pm ET
Hercules Capital Announces Date for Release of Second Quarter 2020 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2020 financial re
Jun 09, 2020 07:30 am ET
Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022
Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced it has agreed to terms with Hercules Capital, Inc. (NYSE: HTGC) on a debt facility to provide up to...
Jun 08, 2020 06:00 am ET
Hercules Capital Receives SBA “Green Light” Letter Approval to Complete Its Third SBIC License
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that the U.S. Small Business Administration (“SBA”) has iss
Jun 03, 2020 04:10 pm ET
Hercules Capital Completes 5-Year Investment Grade Bond Offering of $70.0 Million of 4.31% Notes due June 2025
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced the completed issuance of a private offering in aggregate principal amount of $70.0 million 4.31% Notes due June 2025 (the “June Notes”). On February 5, 2020, the Company completed the initial issuance of $50.0 million 4.28% Notes due February 2025, which were initially assigned a BBB+ rating by Kroll Bond Rating Agency.
Jun 01, 2020 04:01 pm ET
G1 Therapeutics Announces Flexible Credit Financing for Up to $100 Million with Hercules Capital
G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the company has entered into a debt financing agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to $100 million. G1 plans to use the proceeds to...
May 04, 2020 04:10 pm ET
Hercules Capital Reports First Quarter 2020 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the first quarter ended March 31
May 01, 2020 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the First Quarter of 2020
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Direc
Apr 27, 2020 06:00 am ET
Hercules Capital Announces Date of 2020 Annual Meeting of Stockholders and Special Meeting of Stockholders
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), will conduct both its 2020 Annual Meeting of Stockholders and its Special Meeting of Stockholders by virtual meeting on Friday, June 12, 2020 at 9:00 a.m. and 10:00 a.m. (Pacific Time), respectively. The proxy statement for each meeting will be mailed separately on or about April
Apr 16, 2020 06:00 am ET
Hercules Capital Announces Date for Release of First Quarter 2020 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2020 financial res
Mar 23, 2020 06:00 am ET
Hercules Capital Business and Coronavirus Update
The team at Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) is working collectively with our employees, shareholders, stakeholders, bondholders, rating agencies, portfolio companies, and our venture capital and private equity sponsors to navigate the significant challenges created by the unprecedented COVID-19 (Coronavirus) pand
Feb 20, 2020 04:10 pm ET
Hercules Capital Reports Fourth Quarter and Record Full-Year 2019 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the fourth quarter and full-year
Feb 20, 2020 06:00 am ET
Hercules Capital Strengthens Its Capital Resources with New $400.0 Million Credit Facility to Support Continued Investment Portfolio Growth
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that effective February 20, 2020, it has replaced its existi
Feb 19, 2020 04:12 pm ET
Hercules Capital Announces Supplemental Cash Distribution of $0.08 per Share for the Fourth Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Feb 19, 2020 04:10 pm ET
Hercules Capital Declares Distribution of $0.32 per Share for the Fourth Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a fourth qu
Feb 06, 2020 06:00 am ET
Hercules Capital Announces 5-Year Investment Grade Bond Offering Totaling $120.0 Million
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced a private offering totaling $120.0 million in aggregate principal amount of $50.0 million 4.28% Notes due February 2025 (the “February Notes”) and $70.0 million 4.31% Notes due June 2025 (the “June Notes”).
Jan 30, 2020 06:00 am ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2019 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fou
Jan 14, 2020 06:00 am ET
Hercules Capital Reaches $10.0 Billion Milestone in Total Debt Commitments Since Inception
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has originated more than $10.0 billion in total de
Jan 09, 2020 08:30 am ET
ChemoCentryx Announces Credit Facility of Up to $100 Million with Hercules Capital
ChemoCentryx, Inc., (NASDAQ: CCXI) today announced that the Company has secured a credit facility of up to $100 million provided by Hercules Capital, Inc. (NYSE: HTGC), a leader in customized financing for companies in life sciences and...
Jan 08, 2020 06:00 am ET
Hercules Capital Highlights 2019 Achievements, Setting a New Investment Record with $1.47 Billion in Total New Debt and Equity Commitments
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest specialty financing provider to innovative venture, growth and established stage companies backed by top-tier venture capital and select private equity firms, today announced select investment milestones and operating highlights for 2019.
Dec 30, 2019 08:30 am ET
Myovant Sciences Announces Closing of $400 Million Loan Facility, Repayment of Debt, Board of Director Transitions, and Executive Promotions
Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer, today announced the closing of the previously announced landmark, low-interest (3-month LIBOR plus 3%) loan...
Oct 30, 2019 04:10 pm ET
Hercules Capital Reports Third Quarter 2019 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter
Oct 29, 2019 04:11 pm ET
Hercules Capital Announces Supplemental Cash Distribution of $0.03 per Share for the Third Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has decla
Oct 29, 2019 04:10 pm ET
Hercules Capital Declares Distribution of $0.32 per Share for the Third Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declar
Oct 09, 2019 06:00 am ET
Hercules Announces Date for Release of Third Quarter 2019 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2019 financial result
Sep 18, 2019 06:00 am ET
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. (“KBRA”) has reaffirmed H
Sep 17, 2019 06:00 am ET
Hercules Capital to Discuss Venture Lending Opportunities at the Upcoming Events for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be particip
Aug 01, 2019 04:12 pm ET
Hercules Capital Announces Supplemental Cash Distribution of $0.02 per Share for the Second Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a supplementa
Aug 01, 2019 04:11 pm ET
Hercules Capital Declares Distribution of $0.32 per Share for the Second Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a second quart
Aug 01, 2019 04:10 pm ET
Hercules Capital Reports Second Quarter 2019 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the second quarter ended June 30, 2
Jul 18, 2019 06:00 am ET
Hercules Capital Appoints Scott Bluestein as Chief Executive Officer and President
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or “the Company”) today announced that its board of directors has appointed Scott Bluestein as Chief Executive Officer and President, effective immediately. Mr. Bluestein, who has held several leadership roles in his nine years with the Company, has served as Hercules’ interim CEO since March 2019 and as Chief Inv
Jul 16, 2019 04:10 pm ET
Hercules Capital Completes Investment Grade Bond Offering of $105.0 Million of 4.77% Notes Due 2024
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced that it has closed a private offering of $105.0 million aggregate principal amount of 4.77% notes due 2024 (the “Notes”).
Jul 11, 2019 06:00 am ET
Hercules Announces Date for Release of Second Quarter 2019 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital and select private equity firms, today announced that it has scheduled its second quarter 2019 financial results conference call for
Jul 01, 2019 06:00 am ET
Hercules Receives a BBB Reaffirmed Investment Grade Corporate Rating from DBRS
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that DBRS, Inc. (“DBRS”) has reaffirmed Hercules’ investment grade corporate rating of BBB
Jun 27, 2019 07:00 am ET
Antares Pharma Announces Amendment to Existing Loan and Security Agreement With Hercules Capital
Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares” or “the Company”) today announced that it has entered into an amendment to its existing loan and security agreement with Hercules Capital, Inc. (NYSE: HTGC), (“Hercules”), to increase the available...
Jun 25, 2019 06:00 am ET
Hercules Capital Announces Multiple Portfolio Company Achievements in Q2 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading U.S. and top tier venture capital and select private equity firms, today announced some of the latest achievements for select portfolio com
Jun 17, 2019 04:10 pm ET
Hercules Capital, Inc. Closes Public Offering of Common Stock Including Option to Purchase Additional Shares
Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company") today
announced that it has closed its underwritten public offering of
5,000,000 shares of its common stock at a public offering price of
$12.64 per share. In addition, the underwriters fully exercised their
over-allotment option to purchase 750,000 additional shares of Hercules’
common stock. Today’s closing included the sale of the over-allotment
shares, bringing the total number of shares sold in this offering to
5,750,000. The underwriters purchased the shares of common stock
Jun 13, 2019 06:00 am ET
Hercules Capital, Inc. Prices Public Offering of Common Stock
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) today announced that it
has priced its public offering of 5,000,000 shares of its common stock
at a public offering price of $12.64 per share for total gross proceeds
of approximately $63.2 million. Hercules has also granted the
underwriters an option to purchase up to an additional 750,000 shares of
its common stock. The offering is subject to customary closing
conditions and is expected to close on June 17, 2019. Morgan Stanley,
Wells Fargo Securities, and Keefe, Bruyette & Woods, A
St
Jun 12, 2019 04:29 pm ET
Hercules Capital, Inc. Announces Public Offering of Common Stock
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) today announced that it
plans to make a public offering of 5,000,000 shares of its common stock.
Hercules also plans to grant the underwriters for the offering an option
to purchase up to an additional 750,000 shares of its common stock.
Morgan Stanley, Wells Fargo Securities, and Keefe, Bruyette & Woods, A
Stifel Company, are acting as joint book-running managers in this
offering, and Compass Point and Wedbush Securities are acting as
co-managers in this offering.
May 15, 2019 06:00 am ET
Hercules Capital to Discuss 2019 Growth Opportunities at the B. Riley FBR Institutional Investor Conference
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the
largest and leading specialty finance provider to innovative, venture
growth stage companies backed by some of the leading and top-tier
venture capital and select private equity firms, today announced that
members of the executive management team will be
May 07, 2019 06:00 am ET
Hercules Capital Appoints Two Senior Investment Professionals in New Leadership Roles
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the
largest specialty financing provider to innovative venture growth stage
companies backed by leading venture capital and private equity firms,
today announced the promotions of R. Bryan Jadot to Head of Life
Sciences Venture Lending and Steve Kuo to Head o
May 02, 2019 04:14 pm ET
Hercules Capital Announces Supplemental Cash Distribution of $0.01 per Share for the First Quarter of 2019
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the
largest and leading specialty financing provider to innovative venture
growth stage companies backed by some of the leading and top-tier
venture capital and select private equity firms, is pleased to announce
that its Board of Directors has declared a sup
May 02, 2019 04:12 pm ET
Hercules Capital Increases its Quarterly Distribution to $0.32 per Share for the First Quarter of 2019
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the
largest and leading specialty finance provider to innovative, venture
growth stage companies backed by some of the leading and top-tier
venture capital and select private equity firms, is pleased to announce
that its Board of Directors has increased and d
May 02, 2019 04:10 pm ET
Hercules Capital Reports First Quarter 2019 Financial Results
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the
largest and leading specialty financing provider to innovative venture
growth stage companies backed by some of the leading and top-tier
venture capital and select private equity firms, today announced its
financial results for the first quarter ended Mar
Apr 11, 2019 06:00 am ET
Hercules Announces Date for Release of First Quarter 2019 Financial Results and Conference Call
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the
leading specialty finance company to innovative, venture growth, pre-IPO
and M&A stage companies backed by leading venture capital and select
private equity firms, today announced that it has scheduled its first
quarter 2019 financial results conference c
Mar 13, 2019 06:00 am ET
Hercules Capital Appoints Robert Badavas as Interim Chairman and Scott Bluestein as Interim Chief Executive Officer
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or “the Company”) today
announced that effective immediately, Manuel Henriquez has voluntarily
stepped aside as Chairman and Chief Executive Officer. The Board has
elected Robert P. Badavas, currently Lead Independent Director to be
Interim Chairman of the Board and elected Sco
Mar 04, 2019 06:00 am ET
Hercules Capital Named 2018 Specialty Finance Lender of the Year, Americas by Private Debt Investor
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the
largest and leading specialty finance provider to innovative, venture
growth stage companies backed by some of the leading U.S. and top-tier
venture capital and select private equity firms, was named 2018
Specialty Finance Lender of the Year, Americas by
Feb 28, 2019 04:01 pm ET
TG Therapeutics Announces Proposed Public Offering of Common Stock and Closing of $60.0 Million Venture Debt Financing
TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public...
Feb 27, 2019 06:00 am ET
Hercules to Discuss 2019 Growth Opportunities at RBC Financial Institutions Conference
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the
largest and leading specialty finance provider to innovative, venture
growth stage companies backed by some of the leading U.S. and top-tier
venture capital and select private equity firms, today announced that
members of the executive management team wil
Feb 26, 2019 07:35 am ET
Analysis: Positioning to Benefit within Canopy Growth, Procter & Gamble, Hercules Capital, On Deck Capital, Ball, and Sun Life Financial — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Canopy Growth Corporation (NYSE:CGC), Procter & Gamble Company (NYSE:PG),...
Feb 21, 2019 04:15 pm ET
Hercules Capital Announces its 54th Consecutive Quarterly Distribution of $0.31 per Share for the Fourth Quarter of 2018
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the
largest and leading specialty finance provider to innovative, venture
growth stage companies backed by some of the leading U.S. and top-tier
venture capital and select private equity firms, is pleased to announce
that its Board of Directors has declared a
Feb 21, 2019 04:10 pm ET
Hercules Capital Reports Record Fourth Quarter and Full-Year 2018 Financial Results
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the
largest and leading specialty financing provider to innovative venture
growth stage companies backed by leading venture capital and select
private equity firms, today announced its financial results for the
fourth quarter and full-year ended December 31,
Feb 21, 2019 06:00 am ET
Hercules Capital Appoints Seth Meyer as Chief Financial Officer
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the
largest and leading specialty finance provider to innovative, venture
growth stage companies backed by some of the leading U.S. and top-tier
venture capital and select private equity firms, today announced the
appointment of Seth Meyer as Chief Financial
Feb 20, 2019 05:55 pm ET
Hercules Capital Increases and Strengthens Its Capital Resources with New $200.0 Million Credit Facility to Support Continued Investment Portfolio Growth and Expansion Strategy
Hercules
Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) the largest
and leading specialty finance provider to innovative, venture growth
stage companies backed by some of the leading U.S. and top-tier venture
capital and select private equity firms, today announced that effective
February 20, 2019, it has replaced
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.